Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Alkem Laboratories Ltd (ALKE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4,898.85 +111.05    +2.32%
11:00:02 - Closed. Currency in INR ( Disclaimer )
  • Volume: 91,121
  • Bid/Ask: 4,887.10 / 4,898.85
  • Day's Range: 4,761.60 - 4,930.00
Type:  Equity
Market:  India
ISIN:  INE540L01014 
S/N:  ALKEM
Alkem Laboratories Ltd 4,898.85 +111.05 +2.32%

NS:ALKE Financials

 
This summary provides an overview of the most significant critical numbers from each of the Alkem Laboratories Ltd financial reports, including theAlkem Laboratories Ltd income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the NS:ALKE financials over time via breakdowns of their annual reports.

Alkem Laboratories Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 34,401.7 million compared to INR 30,793.7 million a year ago. Revenue was INR 35,033.6 million compared to INR 31,300.4 million a year ago. Net income was INR 6,205.2 million compared to INR 3,308.4 million a year ago. Basic earnings per share from continuing operations was INR 51.9 compared to INR 27.67 a year ago. Diluted earnings per share from continuing operations was INR 51.9 compared to INR 27.67 a year ago.For the six months, sales was INR 64,078.9 million compared to INR 56,557.5 million a year ago. Revenue was INR 65,369.2 million compared to INR 57,578.3 million a year ago. Net income was INR 9,072.5 million compared to INR 4,584.8 million a year ago. Basic earnings per share from continuing operations was INR 75.88 compared to INR 38.35 a year ago. Diluted earnings per share from continuing operations was INR 75.88 compared to INR 38.35 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ALKE Income Statement & Profits

Gross margin TTM 58.85%
Operating margin TTM 15.22%
Net Profit margin TTM 12.45%
Return on Investment TTM 14.41%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 33238.7 34401.7 29677.2 29026
Gross Profit 20193.3 21131 17691.5 15331.9
Operating Income 6380.3 6728.3 3167.8 2954.9
Net Income 5949.6 6205.2 2867.3 709.8

ALKE Balance Sheet

Quick Ratio MRQ 1.55
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 14.66%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 149256.8 137566.5
Total Liabilities 47011.4 43216.5
Total Equity 102245.4 102245.4 94350 94350

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM 171.76
Revenue/Share TTM 1,056.69
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ALKE Price Commentary

Write your thoughts about Alkem Laboratories Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mahesh Maniya
Mahesh Maniya Jun 21, 2020 13:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buying target 3200 three monthbest returns
Narinder Singh ambala
Narinder Singh ambala May 30, 2020 18:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
fundamentally strong but 2230
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email